Header Logo

Connection

ERIN DOHERTY to Melphalan

Back to Details
This is a "connection" page, showing publications ERIN DOHERTY has written about Melphalan.
ERIN DOHERTY
Connection Strength
0.049
Melphalan
  1. Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma. Bone Marrow Transplant. 2022 04; 57(4):579-585.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.